SCHEMBL3164858

SCHEMBL3164858

CC(=O)NCCNc1cc(NC(=O)CN2CCOCC2)nc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ TSHR P16473 2/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ CLK1 P49759 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ JAK3 P52333 1/20 0.46
▸ ADORA2A P29274 3/20 0.46
▸ ADORA1 P30542 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ GSK3B P49841 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ WNT3A P56704 1/20 0.44
▸ EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164709 0.90 NPC1 (0.47) ALDH1A1NPC1MAPTJAK3ADORA2A
SCHEMBL3163125 0.90 NPC1 (0.47) ALDH1A1NPC1MAPTJAK3ADORA2A
SCHEMBL3162425 0.90 EGFR (0.53) ALDH1A1TSHRSMN1; SMN2MAPTLMNA
SCHEMBL3171920 0.89 ADORA1 (0.47) ALDH1A1CLK1ADORA2AADORA1KDM4E
SCHEMBL3163144 0.89 ADORA3 (0.46) ALDH1A1TSHRSMN1; SMN2MAPTLMNA
SCHEMBL3160939 0.88 ALDH1A1 (0.52) ALDH1A1TSHRSMN1; SMN2LMNAADORA2A
SCHEMBL3169937 0.88 ALDH1A1 (0.48) ALDH1A1ADORA2AADORA1HSD17B10EGFR
SCHEMBL3163746 0.88 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MAPTADORA2AADORA1
SCHEMBL3175543 0.86 EGFR (0.50) ALDH1A1TSHRSMN1; SMN2MAPTLMNA
SCHEMBL3170421 0.86 SMN1; SMN2 (0.55) ALDH1A1TSHRSMN1; SMN2JAK3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback